These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30514002)

  • 1. Insight into Inhibitor Binding in the Eukaryotic Proteasome: Computations of the 20S CP.
    Hodošček M; Elghobashi-Meinhardt N
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30514002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fundamental reaction pathway and free energy profile of proteasome inhibition by syringolin A (SylA).
    Wei D; Tang M; Zhan CG
    Org Biomol Chem; 2015 Jun; 13(24):6857-65. PubMed ID: 26018983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modeling on porphyrin derivatives as β5 subunit inhibitor of 20S proteasome.
    Arba M; Nur-Hidayat A; Ruslin ; Yusuf M; Sumarlin ; Hertadi R; Wahyudi ST; Surantaadmaja SI; Tjahjono DH
    Comput Biol Chem; 2018 Jun; 74():230-238. PubMed ID: 29674291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational inhibition studies of the human proteasome by argyrin-based analogues with subunit specificity.
    Loizidou EZ; Zeinalipour-Yazdi CD
    Chem Biol Drug Des; 2014 Jul; 84(1):99-107. PubMed ID: 24521156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity enhancement of the synthetic syrbactin proteasome inhibitor hybrid and biological evaluation in tumor cells.
    Archer CR; Groll M; Stein ML; Schellenberg B; Clerc J; Kaiser M; Kondratyuk TP; Pezzuto JM; Dudler R; Bachmann AS
    Biochemistry; 2012 Aug; 51(34):6880-8. PubMed ID: 22870914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimerized linear mimics of a natural cyclopeptide (TMC-95A) are potent noncovalent inhibitors of the eukaryotic 20S proteasome.
    Desvergne A; Genin E; Maréchal X; Gallastegui N; Dufau L; Richy N; Groll M; Vidal J; Reboud-Ravaux M
    J Med Chem; 2013 Apr; 56(8):3367-78. PubMed ID: 23540790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational Design of Selective and Bioactive Inhibitors of the Mycobacterium tuberculosis Proteasome.
    Totaro KA; Barthelme D; Simpson PT; Jiang X; Lin G; Nathan CF; Sauer RT; Sello JK
    ACS Infect Dis; 2017 Feb; 3(2):176-181. PubMed ID: 28183185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncovalent inhibitors of human 20S and 26S proteasome based on trypsin inhibitor SFTI-1.
    Dębowski D; Cichorek M; Lubos M; Wójcik S; Łęgowska A; Rolka K
    Biopolymers; 2016 Sep; 106(5):685-96. PubMed ID: 27258473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacophore-based virtual screening for identifying β5 subunit inhibitor of 20S proteasome.
    Arba M; Nur-Hidayat A; Surantaadmaja SI; Tjahjono DH
    Comput Biol Chem; 2018 Dec; 77():64-71. PubMed ID: 30243108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding mode of TMC-95A analogues to eukaryotic 20S proteasome.
    Kaiser M; Groll M; Siciliano C; Assfalg-Machleidt I; Weyher E; Kohno J; Milbradt AG; Renner C; Huber R; Moroder L
    Chembiochem; 2004 Sep; 5(9):1256-66. PubMed ID: 15368577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concise Chemoenzymatic Total Synthesis and Identification of Cellular Targets of Cepafungin I.
    Amatuni A; Shuster A; Adibekian A; Renata H
    Cell Chem Biol; 2020 Oct; 27(10):1318-1326.e18. PubMed ID: 32763140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nostocyclopeptides as New Inhibitors of 20S Proteasome.
    Fidor A; Cekała K; Wieczerzak E; Cegłowska M; Kasprzykowski F; Edwards C; Mazur-Marzec H
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional evidence for citicoline binding and modulation of 20S proteasome activity: Novel insights into its pro-proteostatic effect.
    Sbardella D; Coletta A; Tundo GR; Ahmed IMM; Bellia F; Oddone F; Manni G; Coletta M
    Biochem Pharmacol; 2020 Jul; 177():113977. PubMed ID: 32298691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrocyclic Peptides that Selectively Inhibit the
    Zhang H; Hsu HC; Kahne SC; Hara R; Zhan W; Jiang X; Burns-Huang K; Ouellette T; Imaeda T; Okamoto R; Kawasaki M; Michino M; Wong TT; Toita A; Yukawa T; Moraca F; Vendome J; Saha P; Sato K; Aso K; Ginn J; Meinke PT; Foley M; Nathan CF; Darwin KH; Li H; Lin G
    J Med Chem; 2021 May; 64(9):6262-6272. PubMed ID: 33949190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasome activity imaging and profiling characterizes bacterial effector syringolin A.
    Kolodziejek I; Misas-Villamil JC; Kaschani F; Clerc J; Gu C; Krahn D; Niessen S; Verdoes M; Willems LI; Overkleeft HS; Kaiser M; van der Hoorn RA
    Plant Physiol; 2011 Jan; 155(1):477-89. PubMed ID: 21045122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Synthesis, and Biological Activity of Isosyringolin A.
    Kitahata S; Chiba T; Yoshida T; Ri M; Iida S; Matsuda A; Ichikawa S
    Org Lett; 2016 May; 18(9):2312-5. PubMed ID: 27123978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ridaifen-F conjugated with cell-penetrating peptides inhibits intracellular proteasome activities and induces drug-resistant cell death.
    Tanaka M; Zhu Y; Shionyu M; Ota N; Shibata N; Watanabe C; Mizusawa A; Sasaki R; Mizukami T; Shiina I; Hasegawa M
    Eur J Med Chem; 2018 Feb; 146():636-650. PubMed ID: 29407987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bortezomib Inhibits Open Configurations of the 20S Proteasome.
    Henderson LW; Gautam AKS; Sharon EM; Johnson CR; Rommel NG; Anthony AJ; Russell DH; Jarrold MF; Matouschek A; Clemmer DE
    J Am Soc Mass Spectrom; 2024 Jun; 35(6):1063-1068. PubMed ID: 38748611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceleration of Protein Degradation by 20S Proteasome-Binding Peptides Generated by In Vitro Artificial Evolution.
    Zhu Y; Shigeyoshi K; Hayakawa Y; Fujiwara S; Kishida M; Ohki H; Horibe T; Shionyu M; Mizukami T; Hasegawa M
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach.
    Groll M; Huber R
    Biochim Biophys Acta; 2004 Nov; 1695(1-3):33-44. PubMed ID: 15571807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.